Trial · NCT03167905
CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
NCT03167905, Phase 2, Phase 3, Active not recruiting, KK Women's and Children's Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery). Trials, record NCT03167905. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03167905
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
- NCT number
- NCT03167905
- Status
- Active not recruiting
- Phases
- Phase 2, Phase 3
- Enrollment
- 881 participants, actual
- Lead sponsor
- KK Women's and Children's Hospital
- Conditions
- Depression, Postpartum, Analgesia, Obstetrical, Anesthesia, Obstetrical
- Interventions
- Epidural delivery system, Entonox, Meperidine, Ultiva, Fentanyl, Ropivacaine
- First posted
- 2017-05-30
- Last updated
- 2026-08-06
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The incidence of major postnatal depression in both groups | 6-10 weeks after delivery | Edinburgh Postnatal Depression Scale (EPDS) score\>=13 |
| Primary | The incidence of (clinically significant, probable) postnatal depression in both groups | 6-10 weeks after delivery | Edinburgh Postnatal Depression Scale (EPDS) score\>=10 |
| Secondary | The incidence of acquiring post-delivery persistent pain in both groups | 6-10 weeks after delivery | Pain score\>3 in the perineal, surgical scar or abdomen region that lasts for at least 6 weeks post-delivery |
| Secondary | Pain vulnerability in both groups (1) | Upon recruitment until 6-10 weeks after delivery | Assessment via Pain Catastrophizing Scale (PCS) questionnaire before and after delivery |
| Secondary | Pain vulnerability in both groups (2) | Upon recruitment until 6-10 weeks after delivery | Assessment via Central Sensitisation Inventory (CSI) questionnaire before and after delivery |
| Secondary | Pain vulnerability in both groups (3) | Upon recruitment till end of first stage of labor (1 day) | Assessment via Angle Labor Pain Questionnaire (A-LPQ) during first stage of labor when the participants experience labor pain |
| Secondary | Psychological vulnerability in both groups (1) | Upon recruitment until 5 days after delivery | Assessment via Fear-Avoidance Components Scale (FACS) questionnaire before delivery |
| Secondary | Psychological vulnerability in both groups (2) | Upon recruitment until 5 days after delivery | Assessment via State Trait Anxiety Inventory (STAI) questionnaire before delivery |
| Secondary | Psychological vulnerability in both groups (3) | Upon recruitment until 5 days after delivery | Assessment via Perceived Stress Scale (PSS) questionnaire before delivery |
| Secondary | Pain severity in both groups | During labour till one day after delivery | Pain score\>3 during labour |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03167905
GET https://conductscience.org/api/trials/v1/NCT03167905/registered